A Randomized Double-Blind Placebo-Controlled Trial to Evaluate Prophylactic Effect of Traditional Chinese Medicine Supplementing Qi and Hemostasis Formula on Gastrointestinal Bleeding after Percutaneous Coronary Intervention in Patients at High Risks
Table 5
TCM syndrome score.
Time
ā
Treatment
Control
Statistics
P valueā³
Day 0
Chest pain
0.07(Z)
0.9444
ā
Chest tightness
1.04(Z)
0.2998
Palpitation
-0.58(Z)
0.5614
Shortness of breath
-0.53(Z)
0.5971
Debilitation
-1.44(Z)
0.1503
Dark and purple lip
-0.02(Z)
0.9827
Tongue manifestation
-0.63(Z)
0.5255
Pulse manifestation
-0.32(Z)
0.7489
TCM syndrome score
-1.28(Z)
0.1992
Day 7
Chest pain
0.25(Z)
0.8050
ā
Chest tightness
0.43(Z)
0.6656
Palpitation
0.75(Z)
0.4534
Shortness of breath
0.75(Z)
0.4534
Debilitation
-0.36(Z)
0.7207
Dark and purple lip
0.84(Z)
0.4036
Tongue manifestation
0.75(Z)
0.4534
Pulse manifestation
0.84(Z)
0.4036
TCM syndrome score
0.49(Z)
0.6265
Day 30
Chest pain
0.04(Z)
0.9683
ā
Chest tightness
-0.48(Z)
0.6277
Palpitation
7.72(Z)
<0.0001
Shortness of breath
6.48(Z)
<0.0001
Debilitation
6.22(Z)
<0.0001
Dark and purple lip
4.54(Z)
<0.0001
Tongue manifestation
7.55(Z)
<0.0001
Pulse manifestation
5.73(Z)
<0.0001
TCM syndrome score
7.46(Z)
<0.0001
Day 90
Chest pain
0.23(Z)
0.8206
ā
Chest tightness
-0.94(Z)
0.3447
Palpitation
3.59(Z)
0.0003
Shortness of breath
6.19(Z)
<0.0001
Debilitation
1.53(Z)
0.1259
Dark and purple lip
0.79(Z)
0.4272
Tongue manifestation
4.65(Z)
<0.0001
Pulse manifestation
1.37(Z)
0.1695
TCM syndrome score
4.13(Z)
<0.0001
Note: ā³ on day 0, P value indicated comparison between the 2 arms; on days 7, 30, and 90, P value indicated the degree of improvement after treatment. indicated statistically significant difference between pre- and posttreatment.